![]() Prothena Prothena is a global biotechnology company seeking to fundamentally alter the course of progressive diseases. | ![]() Theravance Biopharma Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses. | Foundation Medicine Foundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies. | Trans Genic Trans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities. | ||
Founding Date | Founding Date 2012 | Founding Date 1996 | Founding Date 2010 | Founding Date 1998 | Founding Date 2017 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | |||||
Locations | Locations Dublin, IE HQ South San Francisco, US | Locations Dublin, IE HQ San Francisco, US | Locations Boston, US HQ Penzberg, DE Morrisville, US San Diego, US | Locations Chiyoda City, JP HQ | Locations Norwich, GB HQ |
Employees | Employees 163 | Employees 97 | Employees 1,8031% decrease | Employees 236 | Employees 215 |
Valuation ($) | Valuation ($) 983.1 m | Valuation ($) 429 m | Valuation ($) N/A | Valuation ($) 25.6 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $9.7m (FY, 2025) | Revenue (est.) $107.5m (FY, 2025) | Revenue (est.) $152.9m (FY, 2017) | Revenue (est.) ¥13.2b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $85.3m (FY, 2017) | Cost of goods ¥10.6b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $107.5m (FY, 2025) | Gross profit $67.6m (FY, 2017) | Gross profit ¥2.6b (FY, 2026) | Gross profit N/A |
Net income | Net income ($244.1m) (FY, 2025) | Net income $105.9m (FY, 2025) | Net income ($161.5m) (FY, 2017) | Net income (¥97.5m) (FY, 2026) | Net income N/A |
Operating ⚠ | |||||
Patents (US) | Patents (US) N/A | Patents (US) 438 (FY, 2018) | Patents (US) 22 (Jul, 2022) | Patents (US) N/A | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 55m | Total funding raised $ 96.5m | Total funding raised N/A | Total funding raised N/A |

Theravance Biopharma is a biopharmaceutical company which provides medicines to treat serious illnesses.
View companyFoundation Medicine is a molecular information company developing clinical diagnostic tests for cancer therapies.
View companyTrans Genic (トランスジェニック) is a company engaged in the development and distribution of genetically engineered animals and antibodies and licensing of these activities.
View companyQuadram Institute is a company specializing in gut health, microbiology, and food.
View company